Patent · US Active

Epinephrine spray formulations

US11517525B2 · kind B2 · utility

0Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2018
Grant dateDec 6, 2022
Priority date
Expiry dateJun 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M11/001
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.